ARTICLE | Company News
Aestus Therapeutics, ALS TDI deal
September 26, 2011 7:00 AM UTC
The partners added additional small molecules to their 2010 deal to evaluate compounds to treat amyotrophic lateral sclerosis (ALS). The expansion was based on positive data from preclinical studies. ...